My heart goes out to all holders. This is a biotech investor's worst nightmare, seeing the flagship product dropped. Here's hoping their cash reserves can come up with a winner in the end. Gotta agree with Swuzz though, they could do a lot worse than drop $6m into SLA and pick up ANZ's 20m share overhang. Would need to be quick though.
a strong buy, page-16
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
